摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-bis-tert-butylcarbamoyl-phenol | 866959-41-3

中文名称
——
中文别名
——
英文名称
3,5-bis-tert-butylcarbamoyl-phenol
英文别名
N,N'-di-tert-butyl-5-hydroxy-isophthalamide;1-N,3-N-ditert-butyl-5-hydroxybenzene-1,3-dicarboxamide
3,5-bis-tert-butylcarbamoyl-phenol化学式
CAS
866959-41-3
化学式
C16H24N2O3
mdl
——
分子量
292.378
InChiKey
IYLLWRVMUZSSRG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    78.4
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1,4-二溴丁烷3,5-bis-tert-butylcarbamoyl-phenolpotassium carbonate 作用下, 以 丙酮 为溶剂, 以73%的产率得到5-(4-bromobutoxy)-N1,N3-di-tert-butylisophthalamide
    参考文献:
    名称:
    Redox-responsive morphology transformation of self-assembled nanostructures based on thiol-disulfide interconversion
    摘要:
    One dimensional (1D) nanotubes and three dimensional (3D) flowerlike supernanostructures were transformed reversibly, which was controlled by the oxidation and reduction cycle of aromatic diamide-derived thiol 1 and disulfide 2, as evidenced by SEM study. Their self-assembling patterns were investigated by UV-vis, H-1 NMR, X-ray crystallographic, and powder X-ray diffraction experiments. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.06.063
  • 作为产物:
    描述:
    N1,N3-bis(1,1-dimethylethyl)-5-(phenylmethoxy)-1,3-benzenedicarboxamide 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇 为溶剂, 50.0 ℃ 、101.33 kPa 条件下, 以99%的产率得到3,5-bis-tert-butylcarbamoyl-phenol
    参考文献:
    名称:
    Redox-responsive morphology transformation of self-assembled nanostructures based on thiol-disulfide interconversion
    摘要:
    One dimensional (1D) nanotubes and three dimensional (3D) flowerlike supernanostructures were transformed reversibly, which was controlled by the oxidation and reduction cycle of aromatic diamide-derived thiol 1 and disulfide 2, as evidenced by SEM study. Their self-assembling patterns were investigated by UV-vis, H-1 NMR, X-ray crystallographic, and powder X-ray diffraction experiments. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.06.063
点击查看最新优质反应信息

文献信息

  • Non-nucleoside reverse transcriptase inhibitors
    申请人:Sweeney Zachary Kevin
    公开号:US20080249151A1
    公开(公告)日:2008-10-09
    Compounds of formula I, wherein R 1 , R 2 , R 3 , R 4 , R 5 , X, Y, and Ar are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.
    式I的化合物,其中R1、R2、R3、R4、R5、X、Y和Ar如本文所定义或其药学上可接受的盐,抑制HIV-1逆转录酶,并提供一种预防和治疗HIV-1感染以及治疗艾滋病和/或ARC的方法。本发明还涉及含有式I化合物的组合物,用于预防和治疗HIV-1感染以及治疗艾滋病和/或ARC。
  • Process for preparing pyridazinone compounds
    申请人:Kertesz John Denis
    公开号:US20050234236A1
    公开(公告)日:2005-10-20
    The present invention provides a process for the preparation 6-[3-(hetero)aryloxy-2-fluoro-benzyl]-2H-pyridazin-3-one compounds 1 where R2 is an optionally substituted aryl or an optionally substituted heteroaryl, R 6 is NO 2 , NH 2 , alkyl, halogen, or a function group readily derived therefrom and R 4c is hydrogen or alkyl. There also is provided a process for the preparation of phenylacetic acid compounds 2, wherein R 2 and R 6 are as defined previously and R 5a is hydrogen or alkyl, which are useful for the preparation of pyridazinone compounds.
    本发明提供了一种制备6-[3-(杂)芳氧基-2-氟苯甲基]-2H-吡啶嗪-3-酮化合物1的方法,其中R2为可任选取代的芳基或可任选取代的杂芳基,R6为NO2、NH2、烷基、卤素或易于由此衍生的功能团,R4c为氢或烷基。本发明还提供了一种制备苯乙酸化合物2的方法,其中R2和R6如前所述定义,R5a为氢或烷基,这些化合物对于制备吡啶嗪酮化合物是有用的。
  • [EN] PROCESS FOR PREPARING PYRIDAZINONE COMPOUNDS<br/>[FR] PROCEDE DE PREPARATION DE COMPOSES A BASE DE PYRIDAZINONE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2005100323A1
    公开(公告)日:2005-10-27
    The present invention provides a process for the preparation 6-[3-(hetero)aryloxy-2-­fluoro-benzyl] -2H-pyridazin-3-one compounds of formula VIII wherein R2 is an optionally substituted aryl or an optionally substituted heteroaryl, X is C1-6 alkyl, halogen, or a function group readily derived therefrom and R5 is H, C02R5a or formula C; R5a is hydrogen or C1-6 alkyl; R4c is hydrogen or C1-6 alkyl.
    本发明提供了一种制备公式VIII中6-[3-(杂)芳氧基-2-氟苯基]-2H-吡啶并[3,2-c][1,2,4]三唑-3-酮化合物的方法,其中R2是可选取代芳基或可选取代杂环芳基,X是C1-6烷基,卤素或易于从中派生的功能基团,R5是H,C02R5a或公式C; R5a是氢或C1-6烷基; R4c是氢或C1-6烷基。
  • Process for preparing 3-aryloxy-phenylacetic acid compounds
    申请人:Roche Palo Alto LLC
    公开号:US07291729B2
    公开(公告)日:2007-11-06
    The present invention provides a process for the preparation of phenylacetic acid compounds 2 where R2 is an optionally substituted aryl, R6 is NO2, NH2, alkyl, halogen, or a function group readily derived there from and R4a is hydrogen C1-6 alkyl, tert-butyl or benzyl The compounds of formula 2a are useful intermediates for the preparation of HIV reverse transcriptase inhibitors
    本发明提供了一种制备苯乙酸化合物2的方法,其中R2是可选取代的芳基,R6是NO2,NH2,烷基,卤素或可从中轻松得到的功能基团,R4a是氢C1-6烷基,叔丁基或苄基。式2a的化合物是制备HIV逆转录酶抑制剂的有用中间体。
  • Phenylacetic acid compounds
    申请人:Kertesz John Denis
    公开号:US20080108810A1
    公开(公告)日:2008-05-08
    The present invention provides a process for the preparation 6-[3-(hetero)aryloxy-2-fluoro-benzyl]-2H-pyridazin-3-one compounds 1 where R2 is an optionally substituted aryl or an optionally substituted heteroaryl, R 6 is NO 2 , NH 2 , alkyl, halogen, or a function group readily derived therefrom and R 4c is hydrogen or alkyl. There also is provided a process for the preparation of phenylacetic acid compounds 2, wherein R 2 and R 6 are as defined previously and R 5a is hydrogen or alkyl, which are useful for the preparation of pyridazinone compounds.
    本发明提供了一种制备6-[3-(杂)芳氧基-2-氟苯基]-2H-吡啶并[3,2-c][1,2,4]三唑-3-酮化合物1的方法,其中R2是可选取代的芳基或可选取代的杂环基,R6是NO2、NH2、烷基、卤素或可由其轻松衍生的官能团,R4是氢或烷基。本发明还提供了一种制备苯乙酸化合物2的方法,其中R2和R6如前所定义,R5是氢或烷基,这些化合物对于制备吡啶并酮化合物是有用的。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫